Management of gout and hyperuricemia.
The medical management of gout follows a logical course in eventually controlling the underlying hyperuricemia. Approached properly, it is one of the most gratifying rheumatic diseases for a physician to treat.
D000493:Allopurinol / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D006073:Gout / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007668:Kidney / Q000378:metabolism; D010353:Patient Education as Topic; D010653:Phenylbutazone / Q000627:therapeutic use; D010754:Phosphoribosyl Pyrophosphate / Q000378:metabolism; D011339:Probenecid / Q000627:therapeutic use; D011687:Purines / Q000378:metabolism; D014527:Uric Acid / Q000097:blood* / Q000378:metabolism; D014528:Uricosuric Agents / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D011687:Purines; D014528:Uricosuric Agents; D014527:Uric Acid; D000493:Allopurinol; D010754:Phosphoribosyl Pyrophosphate; D010653:Phenylbutazone; D011339:Probenecid; D003078:Colchicine; C030985:purine; D007213:Indomethacin